Resistance Mutation R292K Is Induced in Influenza A(H6N2) Virus by Exposure of Infected Mallards to Low Levels of Oseltamivir

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Gillman, Anna ^a   Muradrasoli, Shaman ^b   Söderström, Hanna ^c   Nordh, Johan ^a   Bröjer, Caroline ^b   Lindberg, Richard H ^c   Latorre Margalef, Neus ^d   Waldenström, Jonas ^d   Olsen, Björn ^a   Järhult, Josef D ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d LINNAEUS UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; LYSINE; OSELTAMIVIR; VIRUS HEMAGGLUTININ; VIRUS SIALIDASE; WATER; ZANAMIVIR;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIVIRAL RESISTANCE; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; DUCK; EGG; ENZYME ACTIVITY; GENE MUTATION; HEN; INFLUENZA A; INFLUENZA A (H6N2); INFLUENZA VIRUS A; INFLUENZA VIRUS A H6N2; LIMIT OF QUANTITATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; VIROGENESIS; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS TRANSMISSION; WATER SUPPLY; WILD TYPE;

ANIMALS; ANSERIFORMES; ANTIVIRAL AGENTS; CHICK EMBRYO; COMPUTATIONAL BIOLOGY; DRUG RESISTANCE, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS; INFLUENZA IN BIRDS; MALE; MICROBIAL SENSITIVITY TESTS; MUTATION; NEURAMINIDASE; OSELTAMIVIR; WATER; ZANAMIVIR;

EID: 84881497333     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071230     Document Type: Article

References (59)

1. Patel A, Gorman SE, (2009) Stockpiling antiviral drugs for the next influenza pandemic. Clin Pharmacol Ther 86: 241-243.
2. Wan Po AL, Farndon P, Palmer N, (2009) Maximizing the value of drug stockpiles for pandemic influenza. Emerg Infect Dis 15: 1686-1687.
3. Moscona A, (2009) Global transmission of oseltamivir-resistant influenza. N Engl J Med 360: 953-956.
4. Bloom JD, Gong LI, Baltimore D, (2010) Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 328: 1272-1275.
5. Abed Y, Pizzorno A, Bouhy X, Boivin G, (2011) Role of permissive neuraminidase mutations in influenza A/Brisbane/59/2007-like (H1N1) viruses. PLoS Pathog 7: e1002431.
6. Olsen B, Munster VJ, Wallensten A, Waldenström J, Osterhaus AD, et al. (2006) Global patterns of influenza A virus in wild birds. Science 312: 384-388.
7. Fields BN, Knipe DM, Howley PM (2007) Fields' virology. Philadelphia: Lippincott Williams & Wilkins.
8. Cox NJ, Subbarao K, (2000) Global epidemiology of influenza: past and present. Annu Rev Med 51: 407-421.
9. Brockwell-Staats C, Webster RG, Webby RJ, (2009) Diversity of influenza viruses in swine and the emergence of a novel human pandemic influenza A (H1N1). Influenza Other Respi Viruses 3: 207-213.
10. Guan Y, Vijaykrishna D, Bahl J, Zhu H, Wang J, et al. (2010) The emergence of pandemic influenza viruses. Protein Cell 1: 9-13.
11. Fick J, Lindberg RH, Tysklind M, Haemig PD, Waldenström J, et al. (2007) Antiviral oseltamivir is not removed or degraded in normal sewage water treatment: implications for development of resistance by influenza A virus. PLoS One 2: e986.
12. Söderstrom H, Järhult JD, Olsen B, Lindberg RH, Tanaka H, et al. (2009) Detection of the antiviral drug oseltamivir in aquatic environments. PLoS One 4: e6064.
13. Leknes H, Sturtzel IE, Dye C, (2012) Environmental release of oseltamivir from a Norwegian sewage treatment plant during the 2009 influenza A (H1N1) pandemic. Sci Total Environ 414: 632-638.
14. Takanami R, Ozaki H, Giri RR, Taniguchi S, Hayashi S, (2010) Detection of antiviral drugs oseltamivir phosphate and oseltamivir carboxylate in Neya River, Osaka Japan. Journal of Water and Environment Technology 2010: 363-372.
15. Takanami R, Ozaki H, Giri RR, Taniguchi S, Hayashi S, (2012) Antiviral Drugs Zanamivir and Oseltamivir Found in Wastewater and Surface Water in Osaka, Japan. Journal of Water and Environment Technology 2012: 57-68.
16. Prasse C, Schlusener MP, Schulz R, Ternes TA, (2010) Antiviral drugs in wastewater and surface waters: a new pharmaceutical class of environmental relevance? Environ Sci Technol 44: 1728-1735.
17. Russell RJ, Haire LF, Stevens DJ, Collins PJ, Lin YP, et al. (2006) The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 443: 45-49.
18. Collins PJ, Haire LF, Lin YP, Liu J, Russell RJ, et al. (2008) Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature 453: 1258-1261.
19. Zurcher T, Yates PJ, Daly J, Sahasrabudhe A, Walters M, et al. (2006) Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro. J Antimicrob Chemother 58: 723-732.
20. Orozovic G, Orozovic K, Lennerstrand J, Olsen B, (2011) Detection of resistance mutations to antivirals oseltamivir and zanamivir in avian influenza A viruses isolated from wild birds. PLoS One 6: e16028.
21. Gamblin SJ, Skehel JJ, (2010) Influenza hemagglutinin and neuraminidase membrane glycoproteins. J Biol Chem 285: 28403-28409.
22. Collins PJ, Haire LF, Lin YP, Liu J, Russell RJ, et al. (2009) Structural basis for oseltamivir resistance of influenza viruses. Vaccine 27: 6317-6323.
23. Eshaghi A, Bolotin S, Burton L, Low DE, Mazzulli T, et al. (2009) Genetic microheterogeneity of emerging H275Y influenza virus A (H1N1) in Toronto, Ontario, Canada from the 2007-2008 respiratory season. J Clin Virol 45: 142-145.
24. Zaraket H, Saito R, Suzuki Y, Baranovich T, Dapat C, et al. (2010) Genetic makeup of amantadine-resistant and oseltamivir-resistant human influenza A/H1N1 viruses. J Clin Microbiol 48: 1085-1092.
25. Yang JR, Lin YC, Huang YP, Su CH, Lo J, et al. (2011) Reassortment and mutations associated with emergence and spread of oseltamivir-resistant seasonal influenza A/H1N1 viruses in 2005-2009. PLoS One 6: e18177.
26. Cohen-Daniel L, Zakay-Rones Z, Resnick IB, Shapira MY, Dorozhko M, et al. (2009) Emergence of oseltamivir-resistant influenza A/H3N2 virus with altered hemagglutination pattern in a hematopoietic stem cell transplant recipient. J Clin Virol 44: 138-140.
27. McKimm-Breschkin JL, Sahasrabudhe A, Blick TJ, McDonald M, Colman PM, et al. (1998) Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors. J Virol 72: 2456-2462.
28. Järhult JD, Muradrasoli S, Wahlgren J, Söderstrom H, Orozovic G,et al. Environmental levels of the antiviral oseltamivir induce development of resistance mutation H274Y in influenza A/H1N1 virus in mallards. PLoS One 6: e24742.
29. Bröjer C, Järhult JD, Muradrasoli S, Söderstrom H, Olsen B, et al. (2013) Pathobiology and virus shedding of low-pathogenic avian influenza virus (a/h1n1) infection in mallards exposed to oseltamivir. J Wildl Dis 49: 103-113.
30. WHO (2012) Meetings of the WHO working group on surveillance of influenza antiviral susceptibility- Geneva, November 2011 and June 2012. Wkly Epidemiol Rec 87: 369-374.
31. Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, et al. (2008) The influenza virus resource at the National Center for Biotechnology Information. J Virol 82: 596-601.
32. Ferraris O, Lina B, (2008) Mutations of neuraminidase implicated in neuraminidase inhibitors resistance. J Clin Virol 41: 13-19.
33. Tai CY, Escarpe PA, Sidwell RW, Williams MA, Lew W, et al. (1998) Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071. Antimicrob Agents Chemother 42: 3234-3241.
34. Gubareva LV, Robinson MJ, Bethell RC, Webster RG, (1997) Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en. J Virol 71: 3385-3390.
35. Carr J, Ives J, Kelly L, Lambkin R, Oxford J, et al. (2002) Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo. Antiviral Res 54: 79-88.
36. Herlocher ML, Carr J, Ives J, Elias S, Truscon R, et al. (2002) Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets. Antiviral Res 54: 99-111.
37. Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, et al. (2004) Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364: 759-765.
38. Varghese JN, Smith PW, Sollis SL, Blick TJ, Sahasrabudhe A, et al. (1998) Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase. Structure 6: 735-746.
39. Yen HL, Herlocher LM, Hoffmann E, Matrosovich MN, Monto AS, et al. (2005) Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility. Antimicrob Agents Chemother 49: 4075-4084.
40. Ha Y, Stevens DJ, Skehel JJ, Wiley DC, (2001) X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs. Proc Natl Acad Sci U S A 98: 11181-11186.
41. Watanabe T, Shinya K, Watanabe S, Imai M, Hatta M, et al. (2011) Avian-type receptor-binding ability can increase influenza virus pathogenicity in macaques. J Virol 85: 13195-13203.
42. Hurt AC, Nor'e SS, McCaw JM, Fryer HR, Mosse J, et al. (2010) Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model. J Virol 84: 9427-9438.
43. Stoner TD, Krauss S, DuBois RM, Negovetich NJ, Stallknecht DE, et al. (2010) Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype. J Virol 84: 9800-9809.
44. Russell CA, Fonville JM, Brown AE, Burke DF, Smith DL, et al. (2012) The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science 336: 1541-1547.
45. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, et al. (2012) Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486: 420-428.
46. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, et al. (2012) Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336: 1534-1541.
47. Ilyushina NA, Govorkova EA, Gray TE, Bovin NV, Webster RG, (2008) Human-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 influenza viruses. PLoS Pathog 4: e1000043.
48. Partridge J, Kieny MP, (2010) Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009-2010 and comparison with previous estimates and global action plan targets. Vaccine 28: 4709-4712.
49. Abelin A, Colegate T, Gardner S, Hehme N, Palache A, (2011) Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective. Vaccine 29: 1135-1138.
50. Petersen E, Keld DB, Ellermann-Eriksen S, Gubbels S, Ilkjaer S, et al. (2011) Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v. Scand J Infect Dis 43: 495-503.
51. Doshi S, Kamimoto L, Finelli L, Perez A, Reingold A, et al. (2011) Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009. J Infect Dis 204: 1848-1856.
52. Latorre-Margalef N, Gunnarsson G, Munster VJ, Fouchier RA, Osterhaus AD, et al. (2009) Effects of influenza A virus infection on migrating mallard ducks. Proc Biol Sci 276: 1029-1036.
53. WHO (2005) WHO manual on animal influenza diagnosis and surveillance. www.who.int/csr/resources/publications/influenza/en/whocdscsrncs20025rev.pdf.
54. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR, (2001) Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 146: 2275-2289.
55. Munster VJ, Baas C, Lexmond P, Waldenstrom J, Wallensten A, et al. (2007) Spatial, temporal, and species variation in prevalence of influenza A viruses in wild migratory birds. PLoS Pathog 3: e61.
56. Spackman E, Suarez DL, (2008) Type A influenza virus detection and quantitation by real-time RT-PCR. Methods Mol Biol 436: 19-26.
57. Potier M, Mameli L, Belisle M, Dallaire L, Melancon SB, (1979) Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate. Anal Biochem 94: 287-296.
58. Gubareva LV, Webster RG, Hayden FG, (2002) Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay. Antiviral Res 53: 47-61.
59. Bröjer C, Agren EO, Uhlhorn H, Bernodt K, Mörner T, et al. (2009) Pathology of natural highly pathogenic avian influenza H5N1 infection in wild tufted ducks (Aythya fuligula). J Vet Diagn Invest -587.